Dr. Brian Courtney and Dr. Aman Thind came together in 2007 to build the foundation for a medical device company.

Valued Partnerships

Brian and Aman found out very early in their partnership that they could work well together and complemented each other’s abilities.

They were good at identifying solutions to complex problems with true clinical impact. Brian and Aman also realized the importance of partnerships clinically, academically as well as with government and industry. With this, they decided to build a company together that would build on these partnerships and allow for development of critically important medical devices in Canada.

Conavi's Story


Conavi Medical announces Health Canada clearance

We are pleased to announce that we are now authorized to market and sell the Foresight™ ICE System in Canada. The Foresight ICE System is the first catheter-based ultrasound system capable of providing both 2D and 3D ultrasound images of cardiac anatomy around the circumference of the catheter’s tip.

The authorization comes from Health Canada—Canada’s federal regulator responsible for monitoring and evaluating the safety, effectiveness, and quality of diagnostic and therapeutic medical devices. After evaluating the Foresight ICE System, Health Canada granted a Canadian Medical Device License (MDL)—giving us the clearance needed to market the solution in our home country of Canada.

“Attaining Health Canada approval for our Foresight ICE System represents a key milestone in our mission to provide Canadian physicians with superior visual guidance to achieve improved clinical outcomes” says Murray Maynard, President and CEO of Conavi Medical. “Not only does this approval allow us to begin marketing our technology in Canada, but a device license in our domestic market is key to obtaining regulatory approval in other jurisdictions.”

Read more


Early results from Southlake Regional Health Centre Study

Southlake Regional Health Centre is supporting the first phase of the Foresight ICE Trial using technology initially developed at Sunnybrook Research Institute. This study is looking at the first clinical use and efficacy of 2D forward and 3D intracardiac echocardiography to guide trans-septal punctures during AF ablation procedures. Several patients have already had successful trans-septal puncture supported by the use of the Foresight ICE system.



Conavi Medical announces FDA 510(k) clearance

Conavi Medical (formerly Colibri Technologies) announces FDA 510(k) clearance for its first product, the Foresight ICE System for Intracardiac Echocardiography.

The Foresight ICE System is the first catheter- based ultrasound system capable of providing both 2D and 3D ultrasound images of cardiac anatomy around the circumference of the catheter’s tip. The system includes the dual display Conavi Hummingbird imaging console and the Foresight ICE catheter. These products can be used to support a growing number of minimally invasive cardiovascular procedures performed in the US, such as ablations and other procedures that may require access to targeted regions of the heart.

Read more


Conavi partners with OBIO

The Ontario Bioscience Innovation Organization (OBIO) is a not-for-profit, membership-based organization engaged in the development of an integrated health innovation economy for Ontario and one that will become a global leader in providing health technology products and services to the international marketplace.

OBIO’s priorities are to build companies that can stay here and grow and a sustainable industry that will: strengthen Ontario’s economy; commercialize research output; employ the best-educated, most innovative workers in the world and provide cost effective, value-driven healthcare solutions. Conavi Medical was selected as a Capital Access Advisory Program (CAAP) Company in which OBIO operates downstream from existing entrepreneurship programs and targets the critical issue of access to capital at the “Series A” and later stages of venture financing. Led by OBIO and a North American Steering Committee of life science venture capitalists and serial entrepreneurs, CAAP Companies work closely with a team of CAAP Advisors to address specific goals and objectives to position them for financing success. In addition to investor materials preparation and guidance, CAAP Goals include intellectual property, clinical and regulatory, market access other key strategic items to position companies for financing success

Read more


Japan Lifeline and Conavi enter partnership

Conavi and Japan Lifeline (JLL) have signed an agreement to allow JLL to serve as the exclusive distributor of Conavi’s intracardiac echocardiography imaging system in Japan. The companies are working together to obtain the necessary regulatory and reimbursement approval.

Download our Press Release.


Conavi becomes a proud partner of HTX

From Invention through Innovation to International Invoice, HTX provides non-dilutive project financing to emerging and established Ontario-based companies to develop, produce and commercialize innovative market-leading advanced health technologies. Through its Health Technology Commercialization Program (HTCP), its new REACH Innovation Procurement program, and its MedTech ecosystem support activities, HTX is the leading resource and catalyst for accelerating the growth of Ontario’s MedTech industry. The work supported by this partnership has been supported through financing provided by the Health Technology Commercialization Program through htx.ca – The Health Technology Exchange (HTX) and with the support of Sunnybrook Research Institute. This Program has also been made available through the support of the Ontario Ministry of Research and Innovation (MRI).

Read more


Ontario Centres of Excellence supports Conavi

Ontario Centres of Excellence (OCE) drives the commercialization of cutting-edge research across key market sectors to build the economy of tomorrow and secure Ontario’s global competitiveness. In so doing, we help develop the next generation of innovators and entrepreneurs, and are a key partner of Ontario’s industry, universities, colleges, research hospitals, investors and government. Conavi has been a proud recipient of 5 OCE support projects including three Market Readiness projects and one Collaborate to Commercialize (C2C) project. These projects are focused on new product development and supporting commercialization efforts.



Conavi Medical is founded out of Sunnybrook Research Institute

Sunnybrook Research Institute (SRI) is dedicated not only to leading world-class research, but also to ensuring that the results of that research lead to tangible positive impacts. Conavi Medical is an example of SRI’s capability of moving technology from the lab to the mainstream by licensing technology to companies and creating spin-off companies.

Conavi is Built on Leadership


Dr. Brian Courtney

Executive Chairman,


Dr. Aman Thind


Conavi is Built on Leadership

Executive Team

Stefano E. Picone, CPA/CA

Director of Finance

Michelle Macpherson

Director of Sales and Marketing

Marc Lukacs, PhD

Director of Technology

Chris Jerger, MSEE, P.Eng

Director of Manufacturing

Morteza Aval, P. Eng

Director of Software

Sam Mostafavi

Director of Quality

Board of Directors

Brian Courtney

Executive Chairman

Cameron Piron

President, Synaptive Medical

Kris Shah

President, Baylis Medical

Craig Podolsky

Partner, CPOINT Capital

Joelle Faulkner

President, Area One Farms

Derrick Rolfe

CEO, Bridgebank Capital

Harold Wodlinger (observer)

President, Wodlinger Consulting